Laurence Cooper
Director/Board Member chez Secure Transfusion Solutions, Inc.
Profil
Laurence James Neil Cooper is the founder of CellChorus LLC.
He is currently the Director at Secure Transfusion Solutions, Inc. Laurence's former jobs include being the Chief Executive Officer & Director at Alaunos Therapeutics, Inc. and a Professor at The University of Texas M.D.
Anderson Cancer Center.
He received a doctorate degree from Case Western Reserve University and an undergraduate degree from Kenyon College.
Postes actifs de Laurence Cooper
| Sociétés | Poste | Début |
|---|---|---|
Secure Transfusion Solutions, Inc.
 Secure Transfusion Solutions, Inc. Medical/Nursing ServicesHealth Services Secure Transfusion Solutions, Inc. is a life sciences company based in Austin, TX that aims to increase the quality, safety, and availability of transfusable blood components, starting first with apheresis platelets. STS provides healthcare institutions with safe and consistent service and true supply chain diversification. By partnering with STS, hospital systems diversify their sourcing risks, strengthening their supply chain and putting them in position to meet the transfusion needs of their patients. Customers of STS include some of the most well-respected and innovative medical institutions in the country. The company was founded by Vijai P. Mohan and he has been the CEO since incorporation. | Director/Board Member | 01/01/2019 |
Anciens postes connus de Laurence Cooper
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Executive Officer | 25/02/2021 |
CellChorus LLC
 CellChorus LLC BiotechnologyHealth Technology CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020. | Founder | - |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Formation de Laurence Cooper
| Case Western Reserve University | Doctorate Degree |
| Kenyon College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
CellChorus LLC
CellChorus LLC BiotechnologyHealth Technology CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020. | Health Technology |
Secure Transfusion Solutions, Inc.
Secure Transfusion Solutions, Inc. Medical/Nursing ServicesHealth Services Secure Transfusion Solutions, Inc. is a life sciences company based in Austin, TX that aims to increase the quality, safety, and availability of transfusable blood components, starting first with apheresis platelets. STS provides healthcare institutions with safe and consistent service and true supply chain diversification. By partnering with STS, hospital systems diversify their sourcing risks, strengthening their supply chain and putting them in position to meet the transfusion needs of their patients. Customers of STS include some of the most well-respected and innovative medical institutions in the country. The company was founded by Vijai P. Mohan and he has been the CEO since incorporation. | Health Services |
